SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000891618-03-004378
Filing Date
2003-08-13
Accepted
2003-08-13 16:58:48
Documents
6
Period of Report
2003-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q f92259e10vq.htm 10-Q 268759
3 EXHIBIT 10.34.01 f92259exv10w34w01.txt EX-10.34.01 11187
4 EXHIBIT 10.38 f92259exv10w38.txt EX-10.38 44826
5 EXHIBIT 31.1 f92259exv31w1.txt EX-31.1 3364
6 EXHIBIT 31.2 f92259exv31w2.txt EX-31.2 3363
7 EXHIBIT 32.1 f92259exv32w1.txt EX-32.1 2470
  Complete submission text file 0000891618-03-004378.txt   336047
Mailing Address 3832 BAY CENTER PLACE HAYWARD CA 94545
Business Address 3832 BAY CENTER PL HAYWARD CA 94545 5106709300
LYNX THERAPEUTICS INC (Filer) CIK: 0000913275 (see all company filings)

IRS No.: 943161073 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-22570 | Film No.: 03842162
SIC: 2833 Medicinal Chemicals & Botanical Products